A Drexel University study finds users treat AI mental-health tools as supplements to human therapy — valuing the support while worrying about dependence and misinformation.
New FDA guidance lets many generative-AI clinical tools reach doctors without formal device review. Supporters call it overdue; critics warn of an 'illusion of safety.'
A 2026 industry survey says health systems have stopped piloting AI and started banking returns on it — from radiology reads to drug discovery to the everyday admin that burns out clinicians.
A new collaboration pairs Mayo Clinic's clinical data with Microsoft's AI to build a healthcare-specific model — as adoption across US health systems jumps to 75%.